Navigation Links
Pramod Mahajan Continues to Battle for His Life

Pramod Mahajan the senior and popular BJP leader is languishing in the ICU of Hinduja Hospital in Mumbai; fighting for his life now for five days. //The big question which is in back of everyone’s mind is - if he is going to make it.

Mr.Mahajan continues to be critical despite some reduction in the drugs that are maintaining his blood pressure. Earlier Medindia has published a special report on his bullet injuries indicating the odds against him.

Dr Anupam Verma the Hospital Director said today ''Mahajan's condition has almost been the same since last night. He has however tolerated very slight reduction in requirement of medication to maintain his BP.'' ''His condition continues to remain critical and stable,'' he added.

Mr Mahajan a diabetic is on ventilator support for his lungs. However what is worrying is that his kidneys are functioning poorly and he is requiring dialysis support. The best possible care is being given by team of surgeons and intensivists with support from doctors from abroad.

It is possible that Mr.Mahajan may need a third surgery soon. His pancreas is also injured and this may be giving problems too. Initially it was the liver that kept bleeding and had to be packed with cotton.

Mr. Mahajan was shot at close range by his younger brother on Saturday morning by his younger brother Pravin at his Worli flat in Mumbai. .
'"/>




Page: 1

Related medicine news :

1. Review of Pramod Mahajans Injuries
2. Pramod Mahajan Undergoes Third Surgery
3. Review of Pramod Mahajans Injuries
4. Pramod Mahajan Undergoes Third Surgery
5. 240 Hours And Counting As Mahajan Continues To Battle For Life
6. Rahul Mahajans Condition Is Serious But Stable : Hospital
7. Rahul Mahajans Condition Improving; Vital Parametres Normal
8. Police Team Permitted to Interrogate Rahul Mahajan
9. Police Summoned Apollo Doctors in Rahul Mahajan’s Cas
10. AIIMS Doctors Assists Police in Rahul Mahajan’s Drug Abuse Cas
11. Apollo doctors Summoned in Rahul Mahajan case

Post Your Comments:
(Date:12/3/2009)... , Leading mental health researchers are warning ...s of climate change will be on mental health, yet ...at the UN climate change conference in Copenhagen ...rom the Institute of Psychiatry (IoP) at King,s Co...y scientists into the potential mental health impa...
(Date:12/3/2009)... 20-year study shows it cut risk factors linked t..., THURSDAY, Dec. 3 (HealthDay News) -- Breast-fe...ficantly lower a woman,s risk of metabolic syndrom...tors -- years later, reports a new study appearing...women who didn,t have pregnancy-related (gestation...
(Date:12/3/2009)... , Cindi Kessock receives... Tulsa, OK (PRWEB) December 2, 2009 -- C...m offering HRMS and ERP applications to businesses...Annual Employee Awards., , ,Each year at their com...evement among their employees. This year, Cindi K...
(Date:12/3/2009)... , Insightra Medical, Inc...announced the launch of its new ventral hernia rep...he standard sublay technique, which completely obv...turing. , (PRWEB) Decembe...based medical device company today announced the l...
(Date:12/3/2009)... , , McALLEN, Texas, Dec. 3 /PRNewswire...SG ), announced today that it has acquired three T...Terrace Rehabilitation & Healthcare Center in ...p; Healthcare in Brownsville; and the 95-bed Veran...he acquisitions were effective December 1, 2009. ,...
Breaking Medicine News(10 mins):Health News:Major impacts of climate change expected on mental health 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 2Health News:The Ensign Group Acquires Three Texas Skilled Nursing Facilities 3
...RIE, La., April 15 OrthoSynetics(TM), the largest...dental practices,worldwide, has expanded its sales...ve experience in the orthodontic industry., "Duri...oussos, president and CEO of OrthoSynetics. "The,a...
... the 11 Awards Presented is the Inaugural Randy Pa...ant, EL SEGUNDO, Calif., April 15 The Pancreatic...nnounced today the 2008 Research,Grant Awards reci...six Career Development Awards and one Fellowship A...
...of colon cancer, premature aging poses worries for..., April 15 (HealthDay News) -- Astronauts may be a...ng from the high-energy radiation found in space, ...implications for the long-term space travel necess...
...ts say academics were paid to lend their names to ...s safety , , TUESDAY, April 15 (HealthDay ...ical giant Merck & Co. paid academics to put t...ller. , The company apparently also exaggerated th...
...TINUING SERIES OF PODCASTS FROM PEROT SYSTEMS ON T...HEALTHCARE LOCATION: http://perotsystems.medi... 15 Edition 18, Host: Dr. Kevin Fickenscher - Pe...Orange, California, Perot Systems continues its s...
...LN, Neb., April 15 Mark Hollis, the President of,...edit and debit card,processing in each of MacPract..."his chief concerns in offering this capability we...sident and CEO of Parallel Software stated that "w...
Other Medicine News:Health News:OrthoSynetics(TM) Expands Sales Team; Prepares to Grow 2Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 2Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 3Health News:The Pancreatic Cancer Action Network Announces Its 2008 Research Grant Awards Totaling Over $1 Million in New Research Funding 4Health News: Space Radiation a Risk for Astronauts 2Health News:Key Vioxx Research Was Written by Merck, Documents Allege 2Health News:Key Vioxx Research Was Written by Merck, Documents Allege 3Health News:Key Vioxx Research Was Written by Merck, Documents Allege 4Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 2Health News:HEALTHCARE TECH AND THE WORLD: HOW INFORMATION TECHNOLOGY CAN IMPACT THE PURSUIT OF 'PERFECT CARE' 3Health News:Parallel Software Announces Integrated Credit Card Processing for MacPractice MD, DDS, DC and 20/20 2
(Date:12/2/2009)...ewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEP... U.S. District Court in Delaware against Teva Phar...ent Nos. 7,132,570 (the ",570 Patent"), 7,297,346 ...") for the Cephalon product NUVIGIL® (armodaf...eriod of marketing exclusivity for NUVIGIL that ex...
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Pharmaceutical Contract Manufacturing -...inker.com/p0164248/Pharmaceutical-Contract-Manufac... pharma industry faces numerous challenges in the ... rising cost of new product development, declining...
(Date:12/2/2009)...ewswire-USNewswire/ -- Jupiter Medical Center ha... tools available into its imaging program, the new... system delivers highly detailed images of the hum...d unique applications, including dual breast scann... with renal dysfunction. This results in shorter ...
Breaking Medicine Technology:Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Jupiter Medical Center Announces New High-Definition MRI System 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 1Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 2Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 3Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 4Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 5Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 6Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 7Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 8Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 9Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 10Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 11Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 12Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 13Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 14Pharmacyclics Reports Fourth Quarter and Fiscal 2009 Financial Results 57573 15State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 1State of Oklahoma Offers Invisible Bracelet Health Benefit 57571 2Immucor to Announce Fiscal First Quarter Financial Results on Thursday October 1 2009 57569 1
...w comparable safety for complex patients treated w...y , , NATICK, Mass., Feb. 18 Boston Scientific C...cation of results from its landmark SYNTAX(TM) tri... of Medicine. In the study, percutaneous coronary...) Paclitaxel-Eluting Coronary Stent System was com...
...TLE, Feb. 18 Cell Therapeutics, Inc.,(Nasdaq and ... efficacy data,from the phase III trial of pixantr... benefit for pixantrone when used as single agent ...essive non-Hodgkin,s lymphoma (NHL). On an,intent-...ved a complete,remission did so during the first 2...
Other Medicine Technology:New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 2New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 3New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 4New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial 5Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 2Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 3Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma 4
D-DI TEST CARDS
D-DI LATEX
STA LIATEST D-DI
STACLOT LA 10
Medicine Products: